CARBAMAZEPINE-INDUCED LYMPHADENOPATHY MIMICKING KI-1 (CD30-CELL LYMPHOMA() T)

Citation
W. Yeo et al., CARBAMAZEPINE-INDUCED LYMPHADENOPATHY MIMICKING KI-1 (CD30-CELL LYMPHOMA() T), Pathology, 29(1), 1997, pp. 64-66
Citations number
13
Categorie Soggetti
Pathology
Journal title
ISSN journal
00313025
Volume
29
Issue
1
Year of publication
1997
Pages
64 - 66
Database
ISI
SICI code
0031-3025(1997)29:1<64:CLMK(L>2.0.ZU;2-A
Abstract
A 22 year old male receiving carbamazepine for a bipolar affective dis order presented with pyrexia, generalized rash, lymphadenopathy and he patosplenomegaly. He was thrombocytopenic and liver function tests rev ealed a hepatitic picture. Lymph node histology suggested a T-cell lym phoma with many large cells possessing blastic features, and expressin g CD3 and CD30 antigens, The abnormalities resolved completely within nine weeks of discontinuing carbamazepine, indicating that the present ing lymphadenopathy was secondary to lymphoid activation, ie; a pseudo lymphoma rather than a malignant lymphoma, This is the first reported case of carbamazepine-induced lymphadenopathy with CD30+ cells, It ill ustrates the potential danger of relying too heavily on CD30 positivit y as an indicator of malignancy.